Cargando…

Human Immunodeficiency Virus type-1 reverse transcriptase exists as post-translationally modified forms in virions and cells

BACKGROUND: HIV-1 reverse transcriptase (RT) is a heterodimer composed of p66 and p51 subunits and is responsible for reverse transcription of the viral RNA genome into DNA. RT can be post-translationally modified in vitro which may be an important mechanism for regulating RT activity. Here we repor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Adam J, Carr, Jillian M, Bagley, Christopher J, Powell, Jason, Warrilow, David, Harrich, David, Burrell, Christopher J, Li, Peng
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2625352/ https://www.ncbi.nlm.nih.gov/pubmed/19091128 http://dx.doi.org/10.1186/1742-4690-5-115

Ejemplares similares

Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription
por: Warren, Kylie, et al.
Publicado: (2009)

Isolated HIV-1 core is active for reverse transcription
por: Warrilow, David, et al.
Publicado: (2007)

Strand Transfer and Elongation of HIV-1 Reverse Transcription Is Facilitated by Cell Factors In Vitro
por: Warrilow, David, et al.
Publicado: (2010)

Virion Structure and Composition
por: Burrell, Christopher J., et al.
Publicado: (2017)

HIV-1 Uncoating and Reverse Transcription Require eEF1A Binding to Surface-Exposed Acidic Residues of the Reverse Transcriptase Thumb Domain
por: Rawle, Daniel J., et al.
Publicado: (2018)

Selection of primer-template sequences that bind human immunodeficiency virus reverse transcriptase with high affinity
por: DeStefano, Jeffrey J., et al.
Publicado: (2006)

Reverse transcriptase activity in psoriatic lesions: effects of reverse transcriptase inhibitors on keratinocyte proliferation and differentiation
por: Molès, Jean-Pierre, et al.
Publicado: (2009)

Small RNA existed in commercial reverse transcriptase: primary evidence of functional small RNAs
por: Xu, Jie, et al.
Publicado: (2014)

Anti-feline immunodeficiency virus reverse transcriptase properties of some medicinal and edible mushrooms
por: Seetaha, Supaphorn, et al.
Publicado: (2020)

Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV
por: Wadford, Debra A., et al.
Publicado: (2014)

Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages
por: Kennedy, Edward M., et al.
Publicado: (2010)

Inhibition of Heat Inactivation of Reverse Transcriptase of Human Immunodeficiency Virus Type 1 by Seropositive Sera
por: Nagumo, Toshiyuki, et al.
Publicado: (1992)

HuR interacts with human immunodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells
por: Lemay, Julie, et al.
Publicado: (2008)

Structural coordination between active sites of a CRISPR reverse transcriptase-integrase complex
por: Wang, Joy Y., et al.
Publicado: (2021)

Reverse transcriptases prime DNA synthesis
por: Zabrady, Matej, et al.
Publicado: (2023)

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation
por: Rhee, Soo-Yon, et al.
Publicado: (2016)

A reverse transcriptase ribozyme
por: Samanta, Biswajit, et al.
Publicado: (2017)

Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors
por: Santos, Lucianna Helene, et al.
Publicado: (2015)

Biochemical and structural comparisons of non-nucleoside reverse transcriptase inhibitors against feline and human immunodeficiency viruses
por: Rattanabunyong, Siriluk, et al.
Publicado: (2023)

Mapping the Small RNA Content of Simian Immunodeficiency Virions (SIV)
por: Brameier, Markus, et al.
Publicado: (2013)

Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana
por: Moyo, Sikhulile, et al.
Publicado: (2019)

APOBEC3 selects V179I in HIV-1 reverse transcriptase to provide selective advantage for non-nucleoside reverse transcriptase inhibitor-resistant mutants
por: Dwivedi, Richa, et al.
Publicado: (2022)

Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors
por: Kayondo, Jonathan K., et al.
Publicado: (2015)

Revealing the Mutation Patterns of Drug-Resistant Reverse Transcriptase Variants of Human Immunodeficiency Virus through Proteochemometric Modeling
por: Qiu, Jingxuan, et al.
Publicado: (2021)

Telomerase reverse transcriptase and neurodegenerative diseases
por: Yu, Xin, et al.
Publicado: (2023)

Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition
por: Dai, Lixin, et al.
Publicado: (2011)

Manipulation of an existing crystal form unexpectedly results in interwoven packing networks with pseudo-translational symmetry
por: Reimer, Janice M., et al.
Publicado: (2016)

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
por: Smith, Steven J., et al.
Publicado: (2014)

Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review
por: McKelvey, Brittany A., et al.
Publicado: (2020)

Pre-Existing Mutations in Reverse Transcriptase of Hepatitis B Virus in Treatment-Naive Chinese Patients with Chronic Hepatitis B
por: Xu, Jie, et al.
Publicado: (2015)

The Y271 and I274 Amino Acids in Reverse Transcriptase of Human Immunodeficiency Virus-1 Are Critical to Protein Stability
por: Zhang, Hao-Jie, et al.
Publicado: (2009)

Mutations in the Reverse Transcriptase and Protease Genes of Human Immunodeficiency Virus-1 from Antiretroviral Naïve and Treated Pediatric Patients
por: Bure, Dinesh, et al.
Publicado: (2015)

Click Chemistry-Based Two-Component System for Efficient Inhibition of Human Immunodeficiency Virus (HIV) Reverse Transcriptase (RT)
por: Ledezma, Carlos E., et al.
Publicado: (2020)

High resistance to reverse transcriptase inhibitors among persons infected with human immunodeficiency virus type 1 subtype circulating recombinant form 02_AG in Ghana and on antiretroviral therapy
por: Deletsu, Selase D., et al.
Publicado: (2020)

NMR characterization of HIV-1 reverse transcriptase binding to various non-nucleoside reverse transcriptase inhibitors with different activities
por: Thammaporn, Ratsupa, et al.
Publicado: (2015)

Pre‐existing singleton E138A mutations in the reverse transcriptase gene do not affect the efficacy of first‐line antiretroviral therapy regimens using rilpivirine in human immunodeficiency virus‐infected patients
por: Kuznetsova, Anna, et al.
Publicado: (2022)

Virion Background and Efficiency of Virion Incorporation Determine Susceptibility of Simian Immunodeficiency Virus Env-Driven Viral Entry to Inhibition by IFITM Proteins
por: Wrensch, Florian, et al.
Publicado: (2017)

The reverse transcriptase inhibitor 3TC protects against age‐related cognitive dysfunction
por: Wahl, Devin, et al.
Publicado: (2023)

A novel motif in telomerase reverse transcriptase regulates telomere repeat addition rate and processivity
por: Xie, Mingyi, et al.
Publicado: (2010)

Synthesis and anti-human immunodeficiency virus activity of substituted (o,o-difluorophenyl)-linked-pyrimidines as potent non‐nucleoside reverse transcriptase inhibitors
por: Čechová, Lucie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c9m3ibi9f2d3i3fo8ubigk1d5b